Journal of the American Veterinary Medical Association · 2026
Surgical debulking and electrochemotherapy, including a tetrapolar single-needle electrode, are associated with clinical benefit in dogs with intranasal tumors.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rangel Marcelo Monte Mór, Holanda André Gustavo Alves, Linhares Laís Calazans Menescal, Suzuki Daniela Ota Hisayasu, Bispo Guilherme Andraus, de Nardi Andrigo Barboza
Аннотация
OBJECTIVE: To evaluate the feasibility and preliminary clinical outcomes of surgical debulking combined with electrochemotherapy (ECT) using a multielectrode approach, including a tetrapolar single-needle electrode, in dogs with intranasal tumors.
METHODS: This retrospective observational study included client-owned dogs with intranasal tumors treated from 2017 through 2024 at a veterinary oncology referral center. Dogs were included if they underwent at least 1 surgical procedure combined with intraoperative bleomycin-based ECT using a multielectrode approach and had a minimum follow-up period of 2 months.
RESULTS: 12 dogs were included, and most had advanced local disease (83% stages T3 to T4). Epithelial tumors predominated (91%), mainly adenocarcinoma (42%). Clinical response was observed in all dogs, including complete clinical response in 75% and partial clinical response in 25%. Local progression was documented by CT in 5 dogs (42%). Repeat procedures were performed in 67% of dogs because of persistent clinical signs or tumor progression. The median progression-free interval was 492 days, and the median survival time was 694 days. Treatment-related adverse events were frequent but predominantly mild to moderate, including partial wound dehiscence (50%), crust formation (42%), infection (25%), and oronasal fistula (25%). No procedure-related deaths occurred.
CONCLUSIONS: Surgical debulking combined with ECT using a multielectrode approach, including a tetrapolar single-needle electrode, was feasible and associated with clinical benefit in dogs with intranasal tumors. These findings support further prospective investigation of this approach for intranasal tumors in dogs.
CLINICAL RELEVANCE: This approach may represent a treatment option for dogs with locally advanced intranasal tumors, particularly when radiotherapy is unavailable.
METHODS: This retrospective observational study included client-owned dogs with intranasal tumors treated from 2017 through 2024 at a veterinary oncology referral center. Dogs were included if they underwent at least 1 surgical procedure combined with intraoperative bleomycin-based ECT using a multielectrode approach and had a minimum follow-up period of 2 months.
RESULTS: 12 dogs were included, and most had advanced local disease (83% stages T3 to T4). Epithelial tumors predominated (91%), mainly adenocarcinoma (42%). Clinical response was observed in all dogs, including complete clinical response in 75% and partial clinical response in 25%. Local progression was documented by CT in 5 dogs (42%). Repeat procedures were performed in 67% of dogs because of persistent clinical signs or tumor progression. The median progression-free interval was 492 days, and the median survival time was 694 days. Treatment-related adverse events were frequent but predominantly mild to moderate, including partial wound dehiscence (50%), crust formation (42%), infection (25%), and oronasal fistula (25%). No procedure-related deaths occurred.
CONCLUSIONS: Surgical debulking combined with ECT using a multielectrode approach, including a tetrapolar single-needle electrode, was feasible and associated with clinical benefit in dogs with intranasal tumors. These findings support further prospective investigation of this approach for intranasal tumors in dogs.
CLINICAL RELEVANCE: This approach may represent a treatment option for dogs with locally advanced intranasal tumors, particularly when radiotherapy is unavailable.